As fungi resistant to traditional treatments continue to spread around the globe, researchers from China Pharmaceutical ...

A bacterium makes a molecule that kills drug-resistant fungi in an unusual way — by targeting various phospholipid molecules ...

Scientists have identified strains of one of the world's most dangerous fungal pathogens, already resistant to our most ...

Outcomes of neonatal candidiasis by antifungal class again revealed similar response rates among the classes. Conclusions: We found a predominance of non-albicans Candida infection in children and ...

Brexafemme is the first antifungal in what is only the fourth antifungal class to reach the market, and has data showing activity in three of four MDR infections on the World Health Organization ...

F2G is a biotech company that specializes in developing therapies to treat invasive fungal infections through a novel class of antifungal agents called the orotomides. There are at least 5 million ...

Dosing was initiated in a Phase 1 single and multiple ascending dose study of SCY-247, the Company’s second-generation triterpenoid antifungal in development for the treatment of severe invasive ...